Hubei Jumpcan Pharmaceutical Co Ltd (SHG:600566) — Stock Price

CN¥25.89 CNY
▼ -0.04% today

Hubei Jumpcan Pharmaceutical Co Ltd (SHG:600566) is currently trading at CN¥25.89 CNY, down 0.04% today. Over the past 52 weeks, shares have ranged between CN¥22.19 and CN¥28.95. This page tracks Hubei Jumpcan Pharmaceutical Co Ltd's live share price on the SHG exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Hubei Jumpcan Pharmaceutical Co Ltd (600566) total market value.

Hubei Jumpcan Pharmaceutical Co Ltd (600566) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Hubei Jumpcan Pharmaceutical Co Ltd's daily closing share price and trading volume on the SHG exchange over the past year, giving a clear view of recent price momentum and liquidity.

Hubei Jumpcan Pharmaceutical Co Ltd Income Statement — Revenue, Profit & Earnings by Year

Hubei Jumpcan Pharmaceutical Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue CN¥6.22 Billion CN¥8.02 Billion CN¥9.65 Billion CN¥9.00 Billion CN¥7.63 Billion
Cost of Revenue CN¥1.31 Billion CN¥1.67 Billion CN¥1.78 Billion CN¥1.54 Billion CN¥1.28 Billion
Gross Profit CN¥4.91 Billion CN¥6.35 Billion CN¥7.87 Billion CN¥7.46 Billion CN¥6.35 Billion
Research & Development CN¥385.10 Million CN¥462.03 Million CN¥464.40 Million CN¥553.30 Million CN¥523.44 Million
SG&A CN¥2.09 Billion CN¥432.65 Million CN¥372.78 Million CN¥364.24 Million CN¥316.89 Million
Total Operating Expenses CN¥4.34 Billion CN¥3.49 Billion CN¥4.61 Billion CN¥5.04 Billion CN¥4.42 Billion
Operating Income CN¥1.88 Billion CN¥2.86 Billion CN¥3.26 Billion CN¥2.42 Billion CN¥1.93 Billion
EBITDA — CN¥2.73 Billion CN¥3.18 Billion CN¥2.56 Billion CN¥1.96 Billion
EBIT — CN¥2.43 Billion CN¥2.88 Billion CN¥2.25 Billion CN¥1.67 Billion
Interest Expense CN¥11.45 Million CN¥27.27 Million CN¥17.58 Million CN¥31.24 Million CN¥35.48 Million
Income Before Tax CN¥2.16 Billion CN¥2.98 Billion CN¥3.30 Billion CN¥2.51 Billion CN¥1.95 Billion
Income Tax Expense — CN¥441.54 Million CN¥470.03 Million CN¥336.20 Million CN¥233.22 Million
Net Income CN¥1.78 Billion CN¥2.53 Billion CN¥2.82 Billion CN¥2.17 Billion CN¥1.72 Billion

Hubei Jumpcan Pharmaceutical Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Hubei Jumpcan Pharmaceutical Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets CN¥17.70 Billion CN¥18.46 Billion CN¥18.14 Billion CN¥14.98 Billion CN¥12.13 Billion
Total Current Assets CN¥14.18 Billion CN¥14.70 Billion CN¥14.24 Billion CN¥11.18 Billion CN¥8.12 Billion
Cash & Equivalents — — — — —
Short-term Investments CN¥6.27 Billion CN¥5.16 Billion CN¥3.18 Billion CN¥3.04 Billion CN¥1.68 Billion
Net Receivables CN¥2.05 Billion CN¥2.27 Billion CN¥2.80 Billion CN¥2.87 Billion CN¥2.19 Billion
Inventory CN¥309.67 Million CN¥569.09 Million CN¥490.08 Million CN¥391.48 Million CN¥375.59 Million
Property, Plant & Equipment — — — CN¥2.86 Billion CN¥3.03 Billion
Goodwill CN¥167.30 Million CN¥167.30 Million CN¥167.30 Million CN¥167.30 Million CN¥167.30 Million
Total Liabilities CN¥3.07 Billion CN¥3.73 Billion CN¥4.77 Billion CN¥3.63 Billion CN¥3.00 Billion
Total Current Liabilities CN¥2.88 Billion CN¥3.54 Billion CN¥4.59 Billion CN¥3.43 Billion CN¥2.80 Billion
Long-term Debt — — — — —
Net Debt — CN¥-5.88 Billion CN¥-6.16 Billion CN¥-4.42 Billion CN¥-3.19 Billion
Total Stockholder Equity CN¥14.61 Billion CN¥14.70 Billion CN¥13.35 Billion CN¥11.34 Billion CN¥9.12 Billion
Retained Earnings CN¥10.04 Billion CN¥10.18 Billion CN¥8.85 Billion CN¥6.84 Billion CN¥5.27 Billion

Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Hubei Jumpcan Pharmaceutical Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow CN¥1.20 Billion CN¥2.18 Billion CN¥3.46 Billion CN¥2.62 Billion CN¥1.89 Billion
Capital Expenditures CN¥95.86 Million CN¥174.34 Million CN¥301.64 Million CN¥243.66 Million CN¥248.32 Million
Free Cash Flow CN¥1.10 Billion CN¥2.00 Billion CN¥3.16 Billion CN¥2.38 Billion CN¥1.65 Billion
Investing Cash Flow — CN¥-2.04 Billion CN¥-476.35 Million CN¥-1.50 Billion CN¥-673.30 Million
Financing Cash Flow — CN¥-1.21 Billion CN¥-150.69 Million CN¥-117.58 Million CN¥-361.19 Million
Dividends Paid CN¥1.93 Billion CN¥1.20 Billion CN¥811.11 Million CN¥604.03 Million CN¥399.72 Million
Stock-Based Compensation — — — CN¥4.64 Million —
Depreciation CN¥310.64 Million CN¥308.02 Million CN¥304.11 Million CN¥308.80 Million CN¥293.81 Million
Change in Cash CN¥-1.23 Billion CN¥-1.07 Billion CN¥2.92 Billion CN¥999.94 Million CN¥859.84 Million

Hubei Jumpcan Pharmaceutical Co Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Hubei Jumpcan Pharmaceutical Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Aug 13, 2023 0.72 — —
Apr 17, 2023 0.62 — —
Oct 23, 2022 0.64 — —
Aug 19, 2022 0.49 — —
Apr 22, 2022 0.64 — —
Oct 29, 2021 0.47 — —
Aug 20, 2021 0.46 — —
Apr 16, 2021 0.35 — —